Peginterferon beta-1a Subcutaneous and Thrombotic microangiopathy
Result of checking the interaction of drug Peginterferon beta-1a Subcutaneous and disease Thrombotic microangiopathy for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Cases of thrombotic microangiopathy (TMA), including thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, some fatal, have been reported with interferon beta products. Discontinue therapy if clinical symptoms and laboratory findings are consistent with TMA, and manage as clinically indicated. Care should be taken when prescribing this agent to patients at risk of endothelial injury.
Generic Name: peginterferon beta-1a
Brand Name: Plegridy, Plegridy Pen, Plegridy Pen Starter Pack, Plegridy Starter Pack
Synonyms: Peginterferon beta-1a, Peginterferon Beta-1a
Peginterferon beta-1a Subcutaneous - mikroangiopatia zakrzepowa 
Peginterferon beta-1a Subcutaneous - microangiopatia trombótica 
Peginterferon beta-1a Subcutaneous - mikroangiopati trombotik 
Peginterferon beta-1a Subcutaneous - mikroangiopati trombotik 
Peginterferon beta-1a Subcutaneous - microangiopatia trombotica 
Peginterferon beta-1a Subcutaneous - microangiopathie thrombotique 
Peginterferon beta-1a Subcutaneous - thrombotische Mikroangiopathie 
Peginterferon beta-1a Subcutaneous - microangiopatía trombótica 
Peginterferon beta-1a Subcutaneous - тромботическая микроангиопатия 
Peginterferon beta-1a Subcutaneous - trombotik mikroanjiyopati 
Peginterferon beta-1a Subcutaneous - اعتلال الأوعية الدقيقة الخثاري 
Peginterferon beta-1a Subcutaneous - 血栓性微血管病